The life and death of oligodendrocytes in vanishing white matter disease

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 6, 2004, Pages 618-630

  Van Haren, Keith ^a   Van Der Voorn, J Patrick ^b   Peterson, Derick R ^a   Van Der Knaap, Marjo S ^b   Powers, James M ^a,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Apoptosis; Myelin; Oligodendrocytes; Translation Initiation; White Matter

Indexed keywords

CASPASE 3; GUANINE NUCLEOTIDE EXCHANGE FACTOR; KI 67 ANTIGEN; MYELIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN;

ADOLESCENT; ADULT; AGE; APOPTOSIS; ARTICLE; ATAXIA; BRAIN; CELL COUNT; CELL DEATH; CELL DENSITY; CELL LABELING; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CEREBELLUM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MICROSCOPY; NICK END LABELING; OLIGODENDROGLIA; PONS ANGLE; PRIORITY JOURNAL; PROTEIN DEFECT; TRANSLATION INITIATION; VANISHING WHITE MATTER DISEASE; WHITE MATTER;

EID: 2942568003     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.6.618     Document Type: Article

References (44)

1. van der Knaap MS, Barth PG, Gabreels FJ, et al. A new leukoencephalopathy with vanishing white matter. Neurology 1997;48:845-55
2. Schiffmann R, Moller JR, Trapp BD, et al. Childhood ataxia with diffuse central nervous system hypomyelination. Ann Neurol 1994;35:331-40
3. van der Knaap MS, Kamphorst W, Barth PG, Kraaijeveld CL, Gut E, Valk J. Phenotypic variation in leukoencephalopathy with vanishing white matter. Neurology 1998;51:540-47
4. Leegwater PA, Vermeulen G, Könst AA, et al. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet 2001;29:383-88
5. Leegwater PA, Könst AA, Kuyt B, et al. The gene for leukoencephalopathy with vanishing white matter is located on chromosome 3q27. Am J Hum Genet 1999;65:728-34
6. van der Knaap MS, Leegwater PA, Könst AA, et al. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 2002;51:264-70
7. Wong K, Armstrong RC, Gyure KA, et al. Foamy cells with oligodendroglial phenotype in childhood ataxia with diffuse central nervous system hypomyelination syndrome. Acta Neuropathol 2000;100:635-46
8. Francalanci P, Eymard-Pierre E, Dionisi-Vici C, et al. Fatal infantile leukodystrophy: A severe variant of CACH/VWM syndrome, allelic to chromosome 3q27. Neurology 2001;57:265-70
9. Brück W, Herms J, Brockmann K, Schulz-Schaeffer W, Hanefeld F. Myelinopathia centralis diffusa (vanishing white matter disease): Evidence of apoptotic oligodendrocyte degeneration in early lesion development. Ann Neurol 2001;50:532
10. Rodriguez D, Gelot A, della Gaspera B, et al. Increased density of oligodendrocytes in childhood ataxia with diffuse central hypomyelination (CACH) syndrome: Neuropathological and biochemical study of two cases. Acta Neuropathol 1999;97:469-80
11. Norton WT. Do oligodendrocytes divide? Neurochem Res 1996;21:495-503
12. Van Haren KP, van der Voorn P, van der Knaap MS, Powers JM. The life and death of oligodendrocytes in vanishing white matter disease [Abstract]. J Neuropathol Exp Neurol 2003;62:580
13. van der Knaap MS, van Berkel CGM, Herms J, et al. eIF2B-Related disorders: Antenatal onset and involvement of multiple organs. Am J Hum Genet 2003;73:1199-207
14. Berry M, Butt AM, Wilkin G, Perry VH. Structural and function of glia in the central nervous system. In: Graham DJ, Lantos PL, eds. Greenfield's neuropathology, 7th edition. London: Arnold, 2002:75-89
15. Morris CS, Esiri MM, Sprinkle TJ, Gregson N. Oligodendrocyte reactions and cell proliferation in human deymyelinating disease. Neuropathol Appl Neurobiol 1994;20:272-81
16. Antonsson B. Bax and other pro-apoptotic bcl-2 family "killer-proteins" and their victim, the mitochondrion. Cell Tissue Res 2001;306:347-61
17. Hara A, Hirose Y, Wang A, Yoshimi N, Tanaka T, Mori H. Localization of Bax and bcl-2 proteins, regulators of programmed cell death, in the human central nervous system. Virchows Arch 1996;429:249-53
18. Martinou JC, Dubois-Dauphin M, Staple JK, Rodriquez I, Pietra C. Overexpression of bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994;13:1017-30
19. Merry DE, Korsmeyer SJ. Bcl-2 gene family in the nervous system. Annu Rev Neurosci 1997;20:245-67
20. Chiou S-K, Jones MK, Tarnawski AS. Survivin - An anti-apoptosis protein: Its biological roles and implications for cancer and beyond. Med Sci Monit 2003;9:143-47
21. Grinspan J. Cells and signaling in oligodendrocyte development. J Neuropathol Exp Neurol 2002;61:297-306
22. Casaccia-Bonnefil P. Cell death in the oligodendrocyte lineage: A molecular perspective of life/death decisions in development and disease. Glia 2000;29:124-35
23. Barres BA, Schmid R, Sendnter M, Raff MC. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993;118:283-95
24. Raff MC. Size control: The regulation of cell numbers in animal development. Cell 1996;86:173-75
25. Raff MC, Barres BA, Burne JE, Coles HS, Ihizaki Y, Jacobson MD. Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 1993;262:695-700
26. Trapp BD, Nishiyama A, Cheng D, Macklink W. Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol 1997;137:459-68
27. Meikrantz W, Schlegel R. Apoptosis and the cell cycle. J Cell Biochem 1995;58:160-74
28. Jensen NA, Pedersen KM, Celis JE, West MJ. Failure of central nervous system myelination in MBP/c-myc transgenic mice: Evidence for c-myc cytotoxicity. Oncogene 1998;16:2123-29
29. Muir DA, Compston DAS. Growth factor stimulation triggers apoptotic cell death in mature oligodendrocytes. J Neurosci Res 1996;44:1-11
30. Shinoura N, Yoshida Y, Nishimura M, et al. Expression level of bcl-2 determines anti- or proapoptotic function. Cancer Res 1999;59:4119-28
31. Yuan J, Yanker BA. Apoptosis in the nervous system. Nature 2000;407:802-9
32. Huppertz B, Hans-Georg F, Kaufman P. The apoptosis cascade - Morphological and immunohistochemical methods for its visualization. Anat Embryol 1999;200:1-18
33. Gown AM, Willingham MC. Improved detection of apoptotic cells in archival paraffin sections: Immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem 2002;50:449-54
34. Zeiss CJ. The apoptosis-necrosis continuum: Insights from genetically altered mice. Vet Pathol 2003;40:481-95
35. Powers JM, Horoupian DS. Diseases of the central nervous system. In: Damjanov I, Linder J, eds. Anderson's pathology, 10th edition. Philadelphia: Mosby, 1995:2696
36. Graeber MB, Moran LB. Mechanisms of cell death in neurodegenerative diseases: Fashion, fiction, and facts. Brain Pathol 2002;12:385-90
37. Antonawich FJ. Translocation of cytochrome c following transient global ischemia in the gerbil. Neurosci Lett 1999;274:123-26
38. Fujimara M, Morita-Fujimura Y, Murakami K, Kawase M, Chan PH. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1998;18:1239-47
39. Nitatori T, Sato N, Waguri S, et al. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 1995;15:1001-11
40. Namura S, Zhu J, Fink K, et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 1998;18:3659-68
41. Anderson AJ, Su JH, Cotman CW. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci 1996;16:1710-19
42. Auer RN, Sutherland GR. Hypoxia and related conditions. In: Graham DJ, Lantos PL, eds. Greenfield's neuropathology, 7th edition. London: Arnold, 2002:247
43. Ridderstrale Y, Wistrand PJ. Membrane-associated carbonic anhydrase activity in the brain of CA II-deficient mice. J Neurocytol 2000;29:263-69
44. Ludwin SK, Bakker DA. Can oligodendrocytes attached to myelin proliferate? J Neurosci 1988;8:1239-44